Optimind Pharma (XCNQ:OMND) COGS-to-Revenue : 0.00 (As of Nov. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Optimind Pharma COGS-to-Revenue?

Optimind Pharma's Cost of Goods Sold for the three months ended in Nov. 2023 was C$0.00 Mil. Its Revenue for the three months ended in Nov. 2023 was C$0.03 Mil.

Optimind Pharma's COGS to Revenue for the three months ended in Nov. 2023 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Optimind Pharma's Gross Margin % for the three months ended in Nov. 2023 was N/A%.

Optimind Pharma COGS-to-Revenue Historical Data

The historical data trend for Optimind Pharma's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optimind Pharma COGS-to-Revenue Chart

Optimind Pharma Annual Data

Trend

Feb22

Feb23

COGS-to-Revenue

Optimind Pharma Quarterly Data
	Jun21	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23
COGS-to-Revenue	Get a 7-Day Free Trial			-	-	-	-	-

Optimind Pharma COGS-to-Revenue Calculation

Optimind Pharma's COGS to Revenue for the fiscal year that ended in Feb. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0.17
	=	0.00

Optimind Pharma's COGS to Revenue for the quarter that ended in Nov. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0.027
	=	0.00

Optimind Pharma (XCNQ:OMND) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Optimind Pharma's Gross Margin % for the three months ended in Nov. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0.027
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Optimind Pharma COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Optimind Pharma's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Optimind Pharma (XCNQ:OMND) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optimind Pharma Corp (XCNQ:OMND) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

3000 - 77 King Street West, TD Centre, North Tower, PO Box 95, Toronto, ON, CAN, M5K 1G8

Website

https://www.optimindpharma.com

Optimind Pharma Corp is an emerging provider of psychedelic therapies for the masses. It helps people suffering from PTSD, Anxiety, Depression, and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities.

Optimind Pharma (XCNQ:OMND) Headlines

No Headlines